SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (1708)8/29/2000 9:48:58 AM
From: Madharry  Respond to of 2001
 
This is just a starting point so that all the people who want to sell can sell. I perceive a number of things here which make it very cloudy to make any kind of informed decision.
1. management stinks
2. reason for terminating the merger is not clear
3. PR release very ambiguous
4. Lawsuits?
Based on the above why do I want to invest in GLIA? Please someone convince me!



To: Torben Noerup Nielsen who wrote (1708)8/29/2000 9:51:33 AM
From: Vector1  Read Replies (2) | Respond to of 2001
 
Torben,
we need to see if we can track down the FDA letter. The scarry thing is the letter concerns the data on the Adcon L trial. This could range from stuff they have an acceptable answer to, or it could throw the whole adcon franchise into question.
Companies do not exercise MAC clauses lightly. This management team must go.
V1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News